EMD-40088

Single-particle
3.4 Å
EMD-40088
3D View Gallery
Deposition: 15/03/2023
Map released: 18/10/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-40088

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8gje summary report (pdf.gz) Map-8gje FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab

EMD-40088

Single-particle
3.4 Å
EMD-40088
3D View Gallery
Deposition: 15/03/2023
Map released: 18/10/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human immunodeficiency virus 1, Homo sapiens
Sample: CZA97.12 SOSIP.664 in complex with 3BNC117 Fab
Fitted models: 8gje

Deposition Authors: Ozorowski G, Lee JH, Ward AB
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
Ringe RP, Colin P , Ozorowski G, Allen JD , Yasmeen A, Seabright GE, Lee JH, Antanasijevic A, Rantalainen K, Ketas T, Moore JP, Ward AB, Crispin M , Klasse PJ
(2023) PLoS Pathog , 19 , e1011601 - e1011601
PUBMED: 37903160
DOI: doi:10.1371/journal.ppat.1011601
ISSN: 1553-7374